Trilogy Evo Respiratory Device Recalled for Software Pressure Issues
Philips Respironics has recalled Trilogy Evo Universal respiratory devices (model DS2000X11B) for software defects that increase pressure, particularly in pediatric and infant applications.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device recall for a respiratory support device with software defects causing unintended pressure increases in infants and pediatric patients. No hospitalizations or injuries are reported in the source, placing this in the category of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Philips Respironics has recalled the Trilogy Evo Universal respiratory device (model DS2000X11B) due to software defects that affect pressure delivery. Two distinct software issues have been identified: one affecting calibration of pressure delivery to infants and pediatric patients, and another that causes pressure to drift during continuous usage.
Both issues result in unintended pressure increases within the device. For respiratory support equipment used with vulnerable populations, uncontrolled pressure changes pose a risk of harm. The defect affects multiple software versions including 1.02.01.00, 1.03.05.00, 1.03.07.00, 1.04.02.00, 1.04.06, 1.05.01, and 1.06.02.
The device has been distributed worldwide, including throughout the United States, for use in medical facilities and emergency response systems.
The recalled product
- Product
- Trilogy Evo Universal, Product number DS2000X11B
- Manufacturer
- Philips Respironics, Inc.
- Affected units
- 10,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Software version numbers 1.02.01.00
- 1.03.05.00
- 1.03.07.00
- 1.04.02.00
- 1.04.06
- 1.05.01
- and 1.06.02
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Philips Respironics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Philips Respironics, Inc.
See all →- SevereTrilogy EV300 obstruction alarm may take up to four breaths
FDA (Devices) · 2026-04-08
- SevereTrilogy Evo O2 obstruction alarm may take up to four breaths
FDA (Devices) · 2026-04-08
- SevereTrilogy Evo obstruction alarm may take up to four breaths
FDA (Devices) · 2026-04-08
- SevereTrilogy Evo Universal obstruction alarm may take up to four breaths
FDA (Devices) · 2026-04-08
- SevereTrilogy EV300 ventilator recalled as Class I over tidal volume
FDA (Devices) · 2026-04-01
Same hazard · pressure increase
See all →- High2021 Starcraft Telluride RV Propane Regulator Failure Fire Risk
NHTSA · 2021-09-02
- HighTrilogy Evo Ventilator Software Defect May Cause Pressure Increase
FDA (Devices) · 2021-08-25
- HighTrilogy Evo O2 Ventilator Software Issues Affecting Pressure Delivery
FDA (Devices) · 2021-08-25
Similar recalls
- SevereTrilogy Evo Universal Ventilator Recalled Due to Sensor Malfunction Risk
FDA (Devices) · 2024-11-20
- SeverePhilips Trilogy Evo Portable Ventilators Recalled for Inaccurate Oxygen Delivery
FDA (Devices) · 2023-04-12
- CriticalPhilips Respironics Recalls Trilogy EVO Ventilators Due to Software Defect
FDA (Devices) · 2020-02-26
- SeverePhilips Trilogy Evo Ventilator Recall: Potential Loss of Ventilation Due to False Alarm
FDA (Devices) · 2024-04-24
- SevereTrilogy Evo Universal Ventilator Class I Recall—22,237 Units Affected
FDA (Devices) · 2023-06-14
- CriticalTrilogy Evo Ventilator Software Update for Identified Safety Issues
FDA (Devices) · 2024-09-11